AChR α Antibodies

Santa Cruz Biotechnology delivers a wide array of AChR α monoclonal antibodies for research focused on understanding acetylcholine receptors in various biological processes. AChR α monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The AChR α subunit is a critical component of the nicotinic acetylcholine receptor, which mediates synaptic transmission in the nervous system and plays a vital role in muscle contraction and neurotransmission. Dysregulation or dysfunction of AChR α can lead to various neurological disorders, making it an important target for research in neurobiology and pharmacology. Understanding the function of the AChR α subunit can provide insights into therapeutic strategies for conditions such as myasthenia gravis and other neuromuscular diseases. Research into AChR α signaling pathways continues to reveal new aspects of neurotransmitter function and regulation. Investigating AChR α expression patterns helps identify potential therapeutic targets in neurological conditions. Advanced research techniques using AChR α monoclonal antibodies enable detailed analysis of receptor distribution and dynamics. Santa Cruz Biotechnology monoclonal antibodies for AChR α support researchers worldwide in advancing our understanding of neuromuscular junction biology and potential therapeutic applications.